At Pan Cancer T, we are transforming the landscape of cancer treatment with the power of adoptive cell therapy. By focusing on unique cancer-specific targets, we aim to extend the reach of T cell therapies to new patient populations. Our proprietary next-generation gene engineering enhances T cell fitness, designed to prolong the duration of clinical responses. Visit our website.
